These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17970643)

  • 1. Leuprolide acetate: a drug of diverse clinical applications.
    Wilson AC; Meethal SV; Bowen RL; Atwood CS
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1851-63. PubMed ID: 17970643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH agonists: gonadorelin, leuprolide and nafarelin.
    Pace JN; Miller JL; Rose LI
    Am Fam Physician; 1991 Nov; 44(5):1777-82. PubMed ID: 1835275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists.
    Miller BS; Shukla AR
    Clin Ther; 2010 Sep; 32(10):1749-51. PubMed ID: 21194598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.
    Plosker GL; Brogden RN
    Drugs; 1994 Dec; 48(6):930-67. PubMed ID: 7533699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leuprolide acetate: pharmaceutical use and delivery potentials.
    Teutonico D; Montanari S; Ponchel G
    Expert Opin Drug Deliv; 2012 Mar; 9(3):343-54. PubMed ID: 22335366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
    Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
    Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gonadotropin-releasing hormone analogs].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
    Yen SS
    Fertil Steril; 1983 Mar; 39(3):257-66. PubMed ID: 6130985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leuprolide acetate, a GnRH agonist, improves experimental autoimmune encephalomyelitis: a possible therapy for multiple sclerosis.
    Guzmán-Soto I; Salinas E; Hernández-Jasso I; Quintanar JL
    Neurochem Res; 2012 Oct; 37(10):2190-7. PubMed ID: 22832949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles.
    Meyer L; Murphy LA; Gumer A; Reichman DE; Rosenwaks Z; Cholst IN
    Fertil Steril; 2015 Sep; 104(3):637-42. PubMed ID: 26149355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NIH conference. Therapeutic applications of luteinizing-hormone-releasing hormone and its analogs.
    Cutler GB; Hoffman AR; Swerdloff RS; Santen RJ; Meldrum DR; Comite F
    Ann Intern Med; 1985 May; 102(5):643-57. PubMed ID: 3920942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
    Neely EK; Hintz RL; Parker B; Bachrach LK; Cohen P; Olney R; Wilson DM
    J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment.
    Nam HK; Kim HR; Rhie YJ; Lee KH
    J Korean Med Sci; 2017 Mar; 32(3):475-479. PubMed ID: 28145651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auxological and biochemical evaluation of pubertal suppression with the GnRH agonist leuprolide acetate in early and precocious puberty.
    Mul D; de Muinck Keizer-Schrama SM; Oostdijk W; Drop SL
    Horm Res; 1999 Dec; 51(6):270-6. PubMed ID: 10640887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists.
    Schultze-Mosgau A; Griesinger G; Altgassen C; von Otte S; Hornung D; Diedrich K
    Expert Opin Investig Drugs; 2005 Sep; 14(9):1085-97. PubMed ID: 16144493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uses of GnRH agonists.
    Garner C
    J Obstet Gynecol Neonatal Nurs; 1994 Sep; 23(7):563-70. PubMed ID: 7996307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty.
    Kappy M; Stuart T; Perelman A; Clemons R
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1087-9. PubMed ID: 2507570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R; Soros A; Jakubowicz S
    J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.